![Celtaxsys](https://storage.googleapis.com/dealroom-images-production/f1/MTAwOjEwMDpjb21wYW55QHMzLWV1LXdlc3QtMS5hbWF6b25hd3MuY29tL2RlYWxyb29tLWltYWdlcy8yMDE5LzAxLzI4L2FhYjQwNmM0ZDIxNDhjZDEwNmJiMDU3OWJkOWFhNTdi.jpg)
Celtaxsys
VerifiedBiopharmaceutical company, engages in developing and testing drug compounds for treating cancer.
Launch date
Market cap
-
Net debt
-
Enterprise valuation
$180—270m (Dealroom.co estimates Jun 2015.)
Atlanta Georgia (HQ)
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
investor | $0.0 | round | |
N/A | $0.0 | round | |
N/A | $0.0 | round | |
investor investor investor | $0.0 | round | |
investor investor investor investor | $0.0 | round | |
$5.0m | Grant | ||
Total Funding | 000k |
Related Content
Recent News about Celtaxsys
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.